Istituto G. Ronzoni

What Istituto G. Ronzoni does

Istituto G. Ronzoni is a non-profit scientific research foundation based in Milan, Italy, specializing in analytical chemistry applied to heparin, glycosaminoglycans (GAGs), and related complex polysaccharides. Founded in 1927 (with active research operations dating from 1941), the institute occupies approximately 1,000 square meters of laboratory and office space and supports around 29 staff. Its work spans basic and applied carbohydrate science, with particular depth in heparin characterization - a safety-critical pharmaceutical application.

The institute's technology stack combines advanced spectroscopic techniques (nuclear magnetic resonance and mass spectrometry), chromatographic separation methods, and proprietary chemometric models including principal component analysis. It operates a regulatory-grade analytical platform certified under Good Laboratory Practice (since 2011) and AIFA Good Manufacturing Practice (aM-31/2021), with additional MIUR and QuESTIO recognition. Scientific output includes more than 485 peer-reviewed publications since 1964, and the institute convenes the long-standing Glycosaminoglycan Symposium (since 1990/91, 32nd edition in 2025).

The institute's revenue mechanics combine research grants (including EU consortium participation such as the SNIF €4.8M program entered in September 2025), fee-for-service analytical contracts with pharmaceutical and chemical industry clients, industry and private donations, and income from a real estate endowment. Commercial analytical and consulting activities are routed through a 2012 spin-off, CAT G. Ronzoni, which operates as a separate legal entity from the foundation. Collaborator networks span MIT, Uppsala University, UCSD, the University of Liverpool, and NIBSC, among others.

Name

Istituto G. Ronzoni

Legal name

Istituto di Ricerche Chimiche e Biochimiche G. Ronzoni – Fondazione non profit

Website

https://ronzoni.it

Company type

Private

Founded year

1927

Operating status

Operating

Headcount range

11–50 employees

Short description

Istituto G. Ronzoni is a Milan-based non-profit research foundation specializing in analytical chemistry for heparin and glycosaminoglycans. It provides GLP/GMP-certified testing, applied research, and scientific convening services to pharmaceutical, chemical, food industry, and academic clients.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Analytical Services

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Method Development & Validation (ICH/USP) (HLAGADAB)

akta.pro secondary industry

Metabolomics & Lipidomics Services (HLAGANAG)

Keywords

• Pharmaceutical analytical services
• Glycosaminoglycan research
• Heparin characterization
• Contract research organization
• GMP certified testing

Headquarters

HQ city

Milan

HQ country

Italy

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

1. Research Grants and Contracts: Public and private research grants and contracts fund much of the institute's activities. Over the last decade, funding of over one million euros has been invested in training young researchers.
2. Analytical Services: Contract analytical services for pharmaceutical and chemical industries including physico-chemical characterization, method validation, and quality control testing of drug substances and products.
3. Foundation Endowment: The institute's activities are supported by the Foundation endowment, which derives from incomes from real estate investments.
4. Donations and Scholarships: Private donations and bequests support educational and scientific activities. Supporting projects includes scholarships for postgraduate programs or PhD courses.
5. Education Programs: Coordination of student internships from university Masters programs and provision of scholarships for graduates in Chemistry, Pharmacy, Biology and related disciplines.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Core offering

Istituto G. Ronzoni provides contract physico-chemical analytical services to pharmaceutical, chemical, and food industry clients, with a specialization in complex carbohydrates, glycosaminoglycans, and heparin characterization. Services include NMR and mass spectrometry analyses, chemometric data processing, GMP/GLP method validation, and complex API sameness studies. The foundation also conducts foundational research, hosts graduate students and PhD candidates, and operates the CAT G. Ronzoni spin-off focused on peptide-based APIs.

Product overview

Istituto G. Ronzoni is a non-profit research foundation established in 1927, conducting pure and applied research in chemistry and biochemistry with approximately 1,000 sq. meters of laboratory space. The institute's core offerings consist of Analytical Services (physico-chemical characterization and quality control testing for pharmaceutical products), its Centro Alta Tecnologia (CAT) spin-off for advanced non-routine analytical services to chemical and pharmaceutical industries, and Education Programs (PhD hosting, Master internships, thesis work, scholarships, and high school training). Research activities span heparin and glycosaminoglycan structure/biology, new characterization approaches, carbohydrate-protein molecular recognition, structural characterization of complex drugs, polysaccharide derivatives, chemical synthesis, and analytical method development. The institute also organizes the annual Glycosaminoglycan Symposium.

Differentiator

Problem solved

Functional benefit

Products and services

• Physico-Chemical Analytical Characterization Services

Quantifiable outcome

• Key contribution to identifying the contaminant responsible for the 2007-2008 heparin crisis that caused over 100 deaths worldwide
• +1 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

18 partnerships are on record, tiered core and minor.

• Politecnico di MilanocoreStrategic or Co-development Partner · 1 September 2025Collaborating as scientific partner in the SNIF project (Safer and more Sustainable Natural Ingredients for Food Industry) alongside CNR and industrial partners. Together developing a public reference database of authenticated flavour profiles using NMR and metabolomic analysis.
• CNR (National Research Council of Italy)coreStrategic or Co-development Partner · 1 September 2025Collaborating as scientific partner in the SNIF project for development of public reference database of authenticated flavour profiles from natural ingredients.
• SacmarcoreStrategic or Co-development Partner · 1 September 2025Industrial partner in the SNIF project focused on safety, authenticity and sustainability of natural ingredients for the food industry.
• Fratelli Branca DistilleriecoreStrategic or Co-development Partner · 1 September 2025Industrial partner in the SNIF project contributing to research on natural ingredients for food industry applications.
• GB FoodscoreStrategic or Co-development Partner · 1 September 2025Industrial partner in the SNIF project working on sustainable natural ingredients for food industry.
• University of BonncoreStrategic or Co-development PartnerCollaborating institution for the Glycosaminoglycan Symposium since 1990 (32nd edition 2025). University of Bonn (Prof. Gerd Bendas) co-organizes the annual symposium with Ronzoni Institute and University of Münster.
• University of MünstercoreStrategic or Co-development PartnerCollaborating institution for the Glycosaminoglycan Symposium since 1990 (32nd edition 2025). University of Münster (Prof. Martin Götte) co-organizes the annual symposium.
• MIT (Massachusetts Institute of Technology)coreStrategic or Co-development PartnerInternational academic collaboration including joint contribution to solving the 2007-2008 heparin crisis with FDA. Prof. Ram Sasisekharan from MIT serves on the Scientific Advisory Board.
• University of LiverpoolcoreStrategic or Co-development PartnerLong-standing international collaboration in glycosaminoglycan research. Prof. Edwin A. Yates serves on the Scientific Advisory Board. Collaborative research on protein-carbohydrate interactions.
• Keele UniversityminorStrategic or Co-development PartnerInternational academic collaboration in life sciences and glycosaminoglycan research.
• University of PaviacoreStrategic or Co-development PartnerAcademic partner coordinating Master student internships since 2011. Students from Level II Master programs in pharmaceutical sciences attend internships at the institute.
• Università Cattolica del Sacro Cuore (Rome)coreStrategic or Co-development PartnerCollaboration with Faculty of Medicine for hosting Master students in Sistemi di Qualità GxP & ISO for internships.
• Università degli Studi di Milano BicoccacoreStrategic or Co-development PartnerAcademic collaboration including seminars such as Prof. Laura Russo teaching glycobiomaterials courses. Joint research activities in organic chemistry.
• Uppsala UniversitycoreStrategic or Co-development PartnerProf. Ulf Lindahl (Professor Emeritus) serves on the Scientific Advisory Board. Prof. Lindahl is internationally recognized for heparin and heparan sulfate research.
• University of California San DiegocoreStrategic or Co-development PartnerProf. Jeffrey D. Esko from Department of Cellular and Molecular Medicine serves on the Scientific Advisory Board.
• University of TurkuminorStrategic or Co-development PartnerInternational academic collaboration in glycosaminoglycan research.
• NIBSC (National Institute for Biological Standards and Control)minorStrategic or Co-development PartnerCollaboration in standards and control of biological products related to heparin and glycosaminoglycans.
• Centro Alta Tecnologia (CAT) G. RonzonicoreStrategic or Co-development PartnerSpin-off founded in 2012 to provide non-routine analytical characterization to chemical industries. Signed agreement for use of institute's automated instruments and facilities, improving analytical efficiency.

Scale indicators5 records

Recent moves6 records

Expansion highlights3 records

Broad incumbents

• ICON plc: ICON provides laboratory services and central lab testing to support global clinical and pharmaceutical development programs, including advanced analytical techniques for drug characterization. Compares to Ronzoni as a regulated analytical testing provider, but operating at much greater commercial scale across a full clinical CRO footprint.
• Charles River Laboratories: Charles River offers GMP-compliant analytical and biopharmaceutical testing services for drug substance and product characterization alongside its larger CRO portfolio. Comparable to Ronzoni's regulated testing offering but anchored in a much broader drug discovery and manufacturing services platform.
• WuXi AppTec: WuXi AppTec operates one of the world's largest CRO/CDMO platforms including analytical testing, method development, and complex drug characterization for global pharma. Overlaps with Ronzoni's contract analytical services but at far greater scale and broader therapeutic coverage.
• Eurofins BioPharma Product Testing: Eurofins operates the world's largest network of pharmaceutical testing laboratories, offering method development, validation, and release testing including NMR, MS, and chromatography for drug substances and products. Comparable to Ronzoni as a contract analytical testing provider for pharma, but at vastly greater scale and breadth.
• PPD (Pharmaceutical Product Development): PPD operates a global CRO offering analytical and bioanalytical laboratory services for pharmaceutical development. Comparable to Ronzoni as a sponsor of contract pharmaceutical testing services, though addressing a far broader client base.
• SGS Life Sciences: SGS provides laboratory testing services for pharmaceuticals and biologics including physico-chemical characterization, method validation, and batch release testing under GMP. Compares as a broad-based contract testing provider competing for similar pharmaceutical analytical work as Ronzoni.

Direct peers

• LGC Group: LGC Group provides measurement, analytical and reference material services to the pharmaceutical and life sciences sectors, including NMR and MS-based characterization for drug development and quality control. Highly comparable to Ronzoni as a contract analytical laboratory serving regulated pharma clients with similar physico-chemical methodologies.
• Intertek Pharmaceutical Services: Intertek provides GMP-compliant analytical chemistry and drug characterization services to pharmaceutical manufacturers, including method validation and quality control of complex APIs. Closely analogous to Ronzoni's contract analytical testing operating model.
• Almac Group: Almac delivers analytical development, validation, and GMP release testing for small and large molecule drug substances, with particular strength in complex API comparability and biosimilar characterization studies. Directly comparable to Ronzoni's complex API sameness studies and method validation services.
• Cambrex: Cambrex (now part of Eurofins PSS) provides small molecule API manufacturing, analytical development, and method validation services to pharma, with deep expertise in complex and chiral molecules. Analogous to Ronzoni in operating a regulated analytical testing service tightly coupled with chemical research on complex molecules.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/istituto-g-ronzoni

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Istituto G. Ronzoni